logo

For the Inventor, By the Inventor

Lausanne, Switzerland

Amazentis Sa


USPTO Granted Patents = 40



Trademarks = 17

Forward Citations = 274

Loading Chart...
Loading Chart...

31 inventors (with patents filed for the assignee):

goldMedal Christopher Rinsch (37 out of 50 patents)

silverMedal Penelope Andreux (28 out of 32 patents)

bronzeMedal William Blanco-Bose (26 out of 26 patents)

4.  Johan Auwerx (15 out of 21 patents)

5.  Bernard Schneider (15 out of 19 patents)

6.  Laurent Mouchiroud (15 out of 17 patents)

7.  Carmen Sandi (9 out of 10 patents)

8.  Eija Pirinen (9 out of 9 patents)

9.  David Genoux (9 out of 9 patents)

10.  Dongryeol Ryu (6 out of 7 patents)

11.  Charles Thomas (6 out of 6 patents)

12.  Richardus Houtkooper (6 out of 7 patents)

13.  Wolfgang Skranc (5 out of 16 patents)

14.  Anurag Singh (5 out of 7 patents)

15.  Davide D'Amico (4 out of 4 patents)


40 patents:

1. 12576065 - Enhancing autophagy or increasing longevity by administration of urolithins (2026-03-17),
2. 12576064 - Urolithin gummy (pectin) formulations (2026-03-17),
3. 12544358 - Enhancing autophagy or increasing longevity by administration of urolithins (2026-02-10),
4. 12338224 - Process-scale synthesis of urolithin A (2025-06-24),
5. 12310943 - Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders (2025-05-27),
6. 12297182 - Compositions comprising an urolithin compound (2025-05-13),
7. 12220424 - Compositions comprising nicotinamide riboside and a urolithin (2025-02-11),
8. 12109190 - Urolithins as immune response enhancers (2024-10-08),
9. 12036205 - Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders (2024-07-16),
10. 12030863 - Prodrugs of urolithins and uses thereof (2024-07-09),
11. 11969408 - Method for improving mitophagy in subjects (2024-04-30),
12. 11931336 - Enhancing autophagy or increasing longevity by administration of urolithins (2024-03-19),
13. 11931335 - Enhancing autophagy or increasing longevity by administration of urolithins or precursors thereof (2024-03-19),
14. 11925616 - Compositions comprising urolithin compounds (2024-03-12),
15. 11903922 - Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders (2024-02-20),
Amazentis SA is a Swiss biotechnology company specialized in the development of innovative, science-backed products for improving human health spanning cellular health/aging, metabolism, and muscle function. Their mission is to harness scientific advancements to promote healthy aging and improve overall wellbeing. With a focus on pioneering research, cutting-edge technology, and rigorous clinical trials, Amazentis aims to deliver groundbreaking interventions for human health and longevity.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 22 2026

Amazentis Sa
40 Patents

#10 in Lausanne

#343 in Switzerland

#17,015 in the World

Lausanne, CH
Lausanne, Switzerland

Amazentis Sa

Forward Citations = 274

31 inventors:

goldMedal Christopher Rinsch (37 out of 50 patents)

silverMedal Penelope Andreux (28 out of 32 patents)

bronzeMedal William Blanco-Bose (26 out of 26 patents)

4.  Johan Auwerx (15 out of 21 patents)

5.  Bernard Schneider (15 out of 19 patents)

Please report any incorrect information to [email protected]
Loading…